{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T13:35:22Z","timestamp":1787578522618,"version":"build-2736575974"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T00:00:00Z","timestamp":1787529600000},"content-version":"vor","delay-in-days":75,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Anhui Provincial Traditional Chinese Medicine Inheritance and Innovation Research Project","award":["2024CCCX263"],"award-info":[{"award-number":["2024CCCX263"]}]},{"name":"The mechanism study of miR-23c methylation promoting osteosarcoma metastasis by up-regulating HOXB5 expression","award":["GDS20240531888744"],"award-info":[{"award-number":["GDS20240531888744"]}]},{"name":"Graduate Research and Practice Innovation Project of Anhui Medical University","award":["YJS20240091"],"award-info":[{"award-number":["YJS20240091"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-56227-9","type":"journal-article","created":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T17:04:37Z","timestamp":1781111077000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Irisquinone exerts anti-osteosarcoma activity by regulating the PI3K\/AKT signaling pathway"],"prefix":"10.1038","volume":"16","author":[{"given":"Ziheng","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingxing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunjie","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanchao","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,10]]},"reference":[{"key":"56227_CR1","doi-asserted-by":"crossref","unstructured":"Beird, H. C. et al. Osteosarcoma.  Nat. Rev. Dis. Primers 8(1): 1. (2022).","DOI":"10.1038\/s41572-022-00409-y"},{"issue":"10","key":"56227_CR2","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/s41571-021-00519-8","volume":"18","author":"J Gill","year":"2021","unstructured":"Gill, J. & Gorlick, R. Advancing therapy for osteosarcoma. Nat. Rev. Clin. Oncol. 18 (10), 609\u2013624 (2021).","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"1","key":"56227_CR3","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41413-023-00246-z","volume":"11","author":"H Tian","year":"2023","unstructured":"Tian, H. et al. Managing the immune microenvironment of osteosarcoma: the outlook for osteosarcoma treatment. Bone Res. 11 (1), 11 (2023).","journal-title":"Bone Res."},{"issue":"4","key":"56227_CR4","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1002\/cac2.12653","volume":"45","author":"MA Smolle","year":"2025","unstructured":"Smolle, M. A. et al. Incidence of and survival with bone and soft tissue sarcoma: a nation-wide study over four decades. Cancer Commun. 45 (4), 397\u2013400 (2025).","journal-title":"Cancer Commun."},{"issue":"15 Suppl","key":"56227_CR5","doi-asserted-by":"publisher","first-page":"e14508","DOI":"10.1200\/JCO.2018.36.15_suppl.e14508","volume":"36","author":"N Guskova","year":"2018","unstructured":"Guskova, N. et al. Toxicity of high-dose chemotherapy in patients with osteosarcoma. J. Clin. Oncol. 36 (15 Suppl), e14508 (2018).","journal-title":"J. Clin. Oncol."},{"issue":"28","key":"56227_CR6","doi-asserted-by":"publisher","first-page":"e2500632","DOI":"10.1002\/advs.202500632","volume":"12","author":"R Xu","year":"2025","unstructured":"Xu, R. et al. A dual approach with organoid and CRISPR screening reveals ERCC6 as a determinant of cisplatin resistance in osteosarcoma. Adv. Sci. (Weinh). 12 (28), e2500632 (2025).","journal-title":"Adv. Sci. (Weinh)"},{"issue":"1","key":"56227_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12943-024-02213-6","volume":"24","author":"S Li","year":"2025","unstructured":"Li, S. et al. Tailoring traditional Chinese medicine in cancer therapy. Mol. Cancer. 24 (1), 1\u201327 (2025).","journal-title":"Mol. Cancer"},{"key":"56227_CR8","doi-asserted-by":"publisher","first-page":"113376","DOI":"10.1016\/j.biopha.2022.113376","volume":"153","author":"D Wang","year":"2022","unstructured":"Wang, D. et al. The role of metabolic reprogramming in cancer metastasis and potential mechanism of traditional chinese medicine intervention. Biomed. Pharmacother. 153, 113376 (2022).","journal-title":"Biomed. Pharmacother"},{"key":"56227_CR9","first-page":"127","volume":"34","author":"Q Li","year":"2025","unstructured":"Li, Q., Xin, S., Ma, A. R. & Chen, N. Research progress on chemical composition and antitumor effect of iris lactea seeds. China Pharm. 34, 127\u2013128 (2025).","journal-title":"China Pharm."},{"issue":"3","key":"56227_CR10","first-page":"1","volume":"30","author":"J Shan","year":"2003","unstructured":"Shan, J., Ge, H., Hou, Y. & Hou, B. Prospective study of radiosensitizing activity of irisquinone in combination treatment of malignant neoplasms. Chin. J. Clin. Oncol. 30 (3), 1\u20134 (2003).","journal-title":"Chin. J. Clin. Oncol."},{"issue":"3","key":"56227_CR11","first-page":"1","volume":"17","author":"L Fu","year":"2001","unstructured":"Fu, L. et al. Effect of irisquinone on cytotoxicity to the cancer cells with multidrug resistance and its mechanism. Chin. Pharmacol. Bull. 17 (3), 1\u20135 (2001).","journal-title":"Chin. Pharmacol. Bull."},{"issue":"9","key":"56227_CR12","doi-asserted-by":"publisher","first-page":"10","DOI":"10.2174\/0118715206339230241202062826","volume":"25","author":"Q Zhang","year":"2025","unstructured":"Zhang, Q. et al. Irisquinone\u2019s anti-cancer potential: targeting trxr to trigger ros-mediated apoptosis and pyroptosis. Anticancer Agents Med. Chem. 25 (9), 10 (2025).","journal-title":"Anticancer Agents Med. Chem."},{"key":"56227_CR13","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1080\/10717544.2019.1574938","volume":"26","author":"L Gao","year":"2019","unstructured":"Gao, L. et al. The improved antitumor efficacy of continuous intratumoral chemotherapy with cisplatin-loaded implants for the treatment of sarcoma 180 tumor-bearing mice. Drug Deliv. 26, 208\u2013215 (2019).","journal-title":"Drug Deliv"},{"key":"56227_CR14","doi-asserted-by":"publisher","first-page":"116306","DOI":"10.1016\/j.jep.2023.116306","volume":"309","author":"L Zhao","year":"2023","unstructured":"Zhao, L. et al. Network pharmacology, a promising approach to reveal the pharmacology mechanism of chinese medicine formula. J. Ethnopharmacol. 309, 116306 (2023).","journal-title":"J. Ethnopharmacol."},{"issue":"1","key":"56227_CR15","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1146\/annurev-biochem-030222-120000","volume":"93","author":"JM Paggi","year":"2024","unstructured":"Paggi, J. M., Pandit, A. & Dror, R. O. The art and science of molecular docking. Annu. Rev. Biochem. 93 (1), 389\u2013410 (2024).","journal-title":"Annu. Rev. Biochem."},{"key":"56227_CR16","first-page":"1","volume":"10","author":"W Zhang","year":"2019","unstructured":"Zhang, W., Huai, Y., Miao, Z., Qian, A. & Wang, Y. Systems pharmacology for investigation of the mechanisms of action of traditional chinese medicine in drug discovery. Front. Pharmacol. 10, 1\u20138 (2019).","journal-title":"Front. Pharmacol."},{"key":"56227_CR17","doi-asserted-by":"publisher","first-page":"D1138","DOI":"10.1093\/nar\/gkaa891","volume":"49","author":"AP Davis","year":"2021","unstructured":"Davis, A. P. et al. Comparative toxicogenomics database (CTD): update 2021. Nucleic Acids Res. 49, D1138\u2013D1143 (2021).","journal-title":"Nucleic Acids Res."},{"key":"56227_CR18","doi-asserted-by":"publisher","first-page":"W356","DOI":"10.1093\/nar\/gkx374","volume":"45","author":"X Wang","year":"2017","unstructured":"Wang, X. et al. PharmMapper 2017 update: a web server for potential drug target identification with a comprehensive target pharmacophore database. Nucleic Acids Res. 45, W356\u2013W360 (2017).","journal-title":"Nucleic Acids Res."},{"key":"56227_CR19","doi-asserted-by":"publisher","first-page":"W726","DOI":"10.1093\/nar\/gkac297","volume":"50","author":"K Gallo","year":"2022","unstructured":"Gallo, K., Goede, A., Preissner, R. & Gohlke, B. SuperPred 3.0: drug classification and target prediction\u2014a machine learning approach. Nucleic Acids Res. 50, W726\u2013W731 (2022).","journal-title":"Nucleic Acids Res."},{"key":"56227_CR20","doi-asserted-by":"crossref","unstructured":"Gfeller, D. et al. SwissTargetPrediction: a web server for target prediction of bioactive small molecules. Nucleic Acids Res. 42(Web Server issue), W32\u2013W38 (2014).","DOI":"10.1093\/nar\/gku293"},{"key":"56227_CR21","doi-asserted-by":"publisher","first-page":"D115","DOI":"10.1093\/nar\/gkh131","volume":"32","author":"A Rolf","year":"2004","unstructured":"Rolf, A. et al. UniProt: the universal protein knowledgebase. Nucleic Acids Res. 32, D115\u2013D119 (2004).","journal-title":"Nucleic Acids Res."},{"key":"56227_CR22","doi-asserted-by":"publisher","first-page":"D955","DOI":"10.1093\/nar\/gkw1118","volume":"45","author":"Y Wang","year":"2017","unstructured":"Wang, Y. et al. PubChem BioAssay: 2017 update. Nucleic Acids Res. 45, D955\u2013D963 (2017).","journal-title":"Nucleic Acids Res."},{"key":"56227_CR23","doi-asserted-by":"publisher","first-page":"D605","DOI":"10.1093\/nar\/gkaa1074","volume":"49","author":"D Szklarczyk","year":"2021","unstructured":"Szklarczyk, D. et al. The string database in 2021: customizable protein-protein networks, and functional characterization of user-uploaded gene\/measurement sets. Nucleic Acids Res. 49, D605\u2013D612 (2021).","journal-title":"Nucleic Acids Res."},{"issue":"11","key":"56227_CR24","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1038\/nmeth.2212","volume":"9","author":"R Saito","year":"2012","unstructured":"Saito, R. et al. A travel guide to cytoscape plugins. Nat. Methods. 9 (11), 1069\u20131076 (2012).","journal-title":"Nat. Methods"},{"key":"56227_CR25","doi-asserted-by":"publisher","first-page":"W216","DOI":"10.1093\/nar\/gkac194","volume":"50","author":"BT Sherman","year":"2022","unstructured":"Sherman, B. T. et al. David: a web server for functional enrichment analysis and functional annotation of gene lists (2021update). Nucleic Acids Res. 50, W216\u2013W221 (2022).","journal-title":"Nucleic Acids Res."},{"issue":"2","key":"56227_CR26","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/d41573-019-00010-1","volume":"18","author":"S Crunkhorn","year":"2019","unstructured":"Crunkhorn, S. Role of the protein data bank. Nat. Rev. Drug Discov. 18 (2), 98 (2019).","journal-title":"Nat. Rev. Drug Discov"},{"key":"56227_CR27","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1002\/pro.3934","volume":"30","author":"DS Goodsell","year":"2021","unstructured":"Goodsell, D. S., Sanner, M. F., Olson, A. J. & Forli, S. The autodock suite at 30. Protein Sci. 30, 31\u201343 (2021).","journal-title":"Protein Sci."},{"key":"56227_CR28","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.mad.2016.04.007","volume":"161","author":"TT Renault","year":"2017","unstructured":"Renault, T. T., Dejean, L. M. & Manon, S. A brewing understanding of the regulation of bax function by bcl-xl and bcl-2. Mech. Ageing Dev. 161, 201\u2013210 (2017).","journal-title":"Mech. Ageing Dev."},{"key":"56227_CR29","doi-asserted-by":"publisher","first-page":"D672","DOI":"10.1093\/nar\/gkae909","volume":"53","author":"M Kanehisa","year":"2025","unstructured":"Kanehisa, M. et al. Kegg: biological systems database as a model of the real world. Nucleic Acids Res. 53, D672\u2013D677 (2025).","journal-title":"Nucleic Acids Res."},{"key":"56227_CR30","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1002\/pro.3715","volume":"28","author":"M Kanehisa","year":"2019","unstructured":"Kanehisa, M. Toward understanding the origin and evolution of cellular organisms. Protein Sci. 28, 1947\u20131951 (2019).","journal-title":"Protein Sci."},{"key":"56227_CR31","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. Kegg: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28, 27\u201330 (2000).","journal-title":"Nucleic Acids Res."},{"key":"56227_CR32","doi-asserted-by":"publisher","first-page":"8989","DOI":"10.2147\/CMAR.S287908","volume":"13","author":"S Hecker-Nolting","year":"2021","unstructured":"Hecker-Nolting, S., Langer, T., Blattmann, C., Kager, L. & Bielack, S. S. Current insights into the management of late chemotherapy toxicities in pediatric osteosarcoma patients. Cancer Manag. Res. 13, 8989\u20138998 (2021).","journal-title":"Cancer Manag. Res."},{"issue":"6","key":"56227_CR33","first-page":"1","volume":"34","author":"C Tan","year":"2019","unstructured":"Tan, C. et al. Effects of irisquinone combined with chemotherapeutic drugs on proliferation and apoptosis of tumor cells. Drugs Clin. 34 (6), 1\u20135 (2019).","journal-title":"Drugs Clin."},{"issue":"7","key":"56227_CR34","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1097\/MNM.0000000000000498","volume":"37","author":"H Wang","year":"2016","unstructured":"Wang, H. et al. Radiosensitizing effect of irisquinone on glioma through the downregulation of HIF-1\u03b1 evaluated by 18F-FDG and 18F-FMISO PET\/CT. Nucl. Med. Commun. 37 (7), 705\u2013714 (2016).","journal-title":"Nucl. Med. Commun."},{"key":"56227_CR35","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1007\/s11655-019-3064-0","volume":"26","author":"T Luo","year":"2020","unstructured":"Luo, T. et al. Network pharmacology in research of chinese medicine formula: methodology, application and prospective. Chin. J. Integr. Med. 26, 72\u201380 (2020).","journal-title":"Chin. J. Integr. Med."},{"key":"56227_CR36","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41568-019-0216-7","volume":"20","author":"G Hoxhaj","year":"2020","unstructured":"Hoxhaj, G. & Manning, B. D. The pi3k-akt network at the interface of oncogenic signalling and cancer metabolism. Nat. Rev. Cancer. 20, 74\u201388 (2020).","journal-title":"Nat. Rev. Cancer"},{"key":"56227_CR37","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1755-8794-7-4","volume":"7","author":"ML Kuijjer","year":"2014","unstructured":"Kuijjer, M. L. et al. Kinome and mrna expression profiling of high-grade osteosarcoma cell lines implies akt signaling as possible target for therapy. BMC Med. Genomics. 7, 4 (2014).","journal-title":"BMC Med. Genomics"},{"key":"56227_CR38","doi-asserted-by":"publisher","first-page":"21090","DOI":"10.18632\/aging.203261","volume":"13","author":"K Zhang","year":"2021","unstructured":"Zhang, K., Wu, S., Wu, H., Liu, L. & Zhou, J. Effect of the notch1-mediated pi3k-akt-mtor pathway in human osteosarcoma. Aging (Albany NY). 13, 21090\u201321101 (2021).","journal-title":"Aging (Albany NY)"},{"key":"56227_CR39","first-page":"206","volume":"56","author":"X Zhao","year":"2020","unstructured":"Zhao, X. et al. Knockdown of ski decreases osteosarcoma cell proliferation and migration by suppressing the pi3k\/akt signaling pathway. Int. J. Oncol. 56, 206\u2013218 (2020).","journal-title":"Int. J. Oncol."},{"key":"56227_CR40","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3892\/mmr.2021.12569","volume":"25","author":"J Zheng","year":"2022","unstructured":"Zheng, J., Liu, C., Shi, J., Wen, K. & Wang, X. Aim2 inhibits the proliferation, invasion and migration, and promotes the apoptosis of osteosarcoma cells by inactivating the pi3k\/akt\/mtor signaling pathway. Mol. Med. Rep. 25, 53 (2022).","journal-title":"Mol. Med. Rep."},{"key":"56227_CR41","doi-asserted-by":"publisher","first-page":"606765","DOI":"10.3389\/fonc.2020.606765","volume":"10","author":"S Ni","year":"2020","unstructured":"Ni, S. et al. Kif21b expression in osteosarcoma and its regulatory effect on osteosarcoma cell proliferation and apoptosis through the pi3k\/akt pathway. Front. Oncol. 10, 606765 (2020).","journal-title":"Front. Oncol."},{"key":"56227_CR42","first-page":"e920766","volume":"26","author":"S Wang","year":"2020","unstructured":"Wang, S., Zhao, G., Zhao, S., Qiao, Y. & Yang, H. The effects of interleukin-33 (il-33) on osteosarcoma cell viability, apoptosis, and epithelial-mesenchymal transition are mediated through the pi3k\/akt pathway. Med. Sci. Monit. 26, e920766 (2020).","journal-title":"Med. Sci. Monit."},{"key":"56227_CR43","doi-asserted-by":"publisher","first-page":"2575","DOI":"10.3892\/or.2017.5530","volume":"37","author":"B Zhu","year":"2017","unstructured":"Zhu, B., Cheng, D., Hou, L., Zhou, S. & Yang, Q. Slc3a2 is upregulated in human osteosarcoma and promotes tumor growth through the pi3k\/akt signaling pathway. Oncol. Rep. 37, 2575\u20132582 (2017).","journal-title":"Oncol. Rep."},{"key":"56227_CR44","doi-asserted-by":"crossref","unstructured":"Liu, L., Geng, H., Mei, C. & Chen, L. Zoledronic acid enhanced the antitumor effect of cisplatin on orthotopic osteosarcoma by ros-pi3k\/akt signaling and attenuated osteolysis. Oxid. Med. Cell Longev. 2021, 6661534 (2021).","DOI":"10.1155\/2021\/6661534"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-56227-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-56227-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-56227-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T13:13:58Z","timestamp":1787577238000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-56227-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,10]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["56227"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-56227-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,10]]},"assertion":[{"value":"25 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"26477"}}